AIT THERAPEUTIC Revenue, Profits - AITB Annual Income Statement

Add to My Stocks
$4.32 $0.04 (0.93%) AITB stock closing price Sep 21, 2018 (Closing)

Financial analysis of AIT THERAPEUTIC involves more than just checking the AIT THERAPEUTIC stock price, by looking at the financial statements of the company in detail. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. Like any other income statement, the AITB income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue decline of 0 when compared to the same period in the past. One also needs to look at AIT THERAPEUTIC assets, operating expenses and AIT THERAPEUTIC free cash flow. The AIT THERAPEUTIC profit and loss statement shows revenue of $- for 2018. Revenue has decreased by 0 YOY for AITB stock.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Apr - Mar201820172016
AIT THERAPEUTIC Revenues or Net Sales
---
Cost Of Goods Sold (COGS)---
AIT THERAPEUTIC Gross Profit
---
Research & Development Expense4.43M1.43M-
Selling General & Admin Expense6.62M2.12M-
Income Before Depreciation Depletion Amortization-11.06M-3.56M-0.92M
Depreciation Depletion Amortization---
Non Operating Income---
Interest Expense6.97M2.71M-
AIT THERAPEUTIC Pretax Income
-18.04M-6.27M-1.26M
Provision for Income Taxes---
MinorityInterest---
Investment Gains Losses---
Other Income---
Income Before Extraordinaries & Disc Operations-18.04M-6.28M-1.27M
Extraordinary Items & Discontinued Operations---
AIT THERAPEUTIC Profit/ Loss (Net Income)
-18.04M-6.28M-1.27M
Average Shares used to compute Diluted EPS6M--
Average Shares used to compute Basic EPS6M--
Income Before Nonrecurring Items-18.04M-0.07M-
Income from Nonrecurring Items---
AIT THERAPEUTIC Earnings Per Share Basic Net
-3.01-0.66-
AIT THERAPEUTIC Earnings Per Share Diluted Net
-3.01-0.66-
EPS Diluted Before Nonrecurring Items-3.01-0.66-
Preferred Dividends Acc Pd---
Dividends Common---
Dividend Per Share Common0.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

The key things to look for in an income statement while doing AIT THERAPEUTIC stock analysis are:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this year of 2018. Our AIT THERAPEUTIC revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-18.04M for AIT THERAPEUTIC for 2018. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The AITB financials along with AIT THERAPEUTIC historical stock prices provide a lot of details about the firm.

AIT THERAPEUTIC Income Statement - Key Financial Ratios